See every side of every news story
Published loading...Updated

Telo appoints John Farlinger to BOD - BioTuesdays

Summary by biotuesdays.com
Telo Genomics (TSXV:TELO) announced the appointment of John Farlinger to its board of directors (BOD) and will serve as chair of the company’s audit committee. With more than 30 years of experience in telecom, operations, technology, and finance, Mr. Farlinger is a veteran venture and private equity backed executive and entrepreneur. He is currently serving as executive chairman and CEO of Assure Neuromonitoring, and is a chartered professional …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biotuesdays.com broke the news in on Friday, April 4, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.